N02C antimigraine antimigrañoso 抗偏头痛药 抗偏頭痛藥 L3
Source: Wikidata · CC0 1.0 Fuente: Wikidata · CC0 1.0 来源:维基数据 · CC0 1.0 來源:維基數據 · CC0 1.0
ATC level L3 · Search this class · Consumer categories
Child classes
N02CAErgot alkaloids Alcaloides del ergot 麦角生物碱类 麥角生物鹼類N02CC[[曲坦类|选择性5-羟色胺 Agonistas selectivos del receptor 5-HT1 [[曲坦类|选择性5-羟色胺 [[曲坦類|選擇性5-羥色胺N02CDCalcitonin gene-related peptide (CGRP) antagonists Calcitonin gene-related peptide (CGRP) antagonists Calcitonin gene-related peptide (CGRP) antagonists Calcitonin gene-related peptide (CGRP) antagonistsN02CXOther antimigraine preparations Otros preparados antimigrañosos 其它抗偏头痛药 其它抗偏頭痛藥
Active ingredients in this class
29 active ingredients 29 principios activos 29 个活性成分 29 個有效成分
The market codes after a status are the markets where that status is recorded (same codes as the product tables). An ingredient can be on sale in one market and withdrawn in another; that is a record fact, not a safety judgement.
- Zolmitriptan
N02CC03withdrawnES·MXdiscontinuedCA·ES·MXactiveUS·GB·CA·AU·SG·CN·ES·MXunknownAU·HK - 依瑞奈尤单抗
N02CDactiveCN - 加卡奈珠单抗
N02CDactiveCN - 安那度尔
N02CXactiveCN - 琥珀酸呋罗曲坦
N02CCactiveCN - 琥珀酸舒马普坦
N02CCactiveCN - 硫酸瑞美吉泮
N02CDactiveCN - 苯甲酸利扎曲普坦
N02CCactiveCN - 麦角胺咖啡因
N02CAactiveCN - Almotriptan
N02CC05Salt form: Almotriptan MalatewithdrawnESdiscontinuedCA·ESactiveUS·GB·CA·ESunknownMX - Atogepant
N02CD07discontinuedESactiveUS·GB·CA·SG·ES·MX·TW·EUunknownAU·HK - Dihydroergotamine
N02CA01discontinuedCAactiveUS·GB·CA - Eletriptan
N02CC06Salt form: Eletriptan HydrobromidediscontinuedCA·MXactiveUS·GB·CA·AU·SG·ES·MXunknownAU·HK - Eptinezumab
N02CD05activeUS·GB·CA·AU·SG·ES·MX·EUunknownAU·HK - Erenumab
N02CD01discontinuedES·MXactiveUS·GB·CA·SG·ES·EUunknownAU·HK - Ergotamine
N02CA52withdrawnMXdiscontinuedCA·MXactiveUS·GB·SG·ES·TWunknownMX·HK - Fremanezumab
N02CD03withdrawnMXdiscontinuedESactiveUS·GB·CA·AU·SG·ES·TW·EUunknownAU·HK - Frovatriptan
N02CC07withdrawnESdiscontinuedCAactiveUS·GB·CA - Galcanezumab
N02CD02discontinuedESactiveUS·GB·CA·AU·SG·ES·TW·EUunknownAU·HK - Lasmiditan
N02CC08discontinuedES·MXactiveUS·ES·EU - Methysergide
N02CA04discontinuedCAactiveGB - Naratriptan
N02CC02Salt form: Naratriptan HydrochloridewithdrawnESdiscontinuedCAactiveUS·GB·CA·AU·SG·ESunknownAU - Pizotifen
N02CX01Salt form: Pizotifen MalatediscontinuedCAactiveGB·CA·AU·CNunknownAU·HK - Pizotifeno
N02CX01activeES - Rimegepant
N02CD06Salt form: Rimegepant SulfateactiveUS·GB·CA·SG·ES·MX·TW·EUunknownAU·HK - Rizatriptan
N02CC04withdrawnESdiscontinuedCA·ESactiveUS·GB·CA·AU·ES·TWunknownAU - Sumatriptan
N02CC01Salt form: Sumatriptan SuccinatewithdrawnES·MXdiscontinuedCA·ES·MXactiveUS·GB·CA·AU·SG·ES·TWunknownAU·MX·HK·EU - Ubrogepant
N02CD04activeUS·CA - Zavegepant
N02CD08activeUS
Class names are editorial translations or come from Wikipedia (CC BY-SA 4.0) / Wikidata (CC0); each ATC page lists the exact source, licence and link for every language. Only the ATC code and the WHO hierarchy are authoritative.
Notes & licences
Status badges summarise the product records held for each ingredient (active / discontinued / withdrawn / unknown), and the market codes after each badge show where that status is recorded. Only some registers publish a status column: CA, ES and MX do; AU and HK have no status column and are recorded as unknown; CN, US, GB, TW and SG records are on the register and marked active.
Class and category names are editorial or AI-assisted translations; only the ATC code and the WHO hierarchy are authoritative.
ATC codes and hierarchy reference the WHO Collaborating Centre for Drug Statistics Methodology ATC/DDD Index (copyright WHOCC; the index itself is not reproduced). Ingredient/strength facts come from the regulator records listed on About.